High killips class as a predictor of new-onset atrial fibrillation following acute myocardial infarction: Systematic review and meta-analysis

Chinese Medical Journal

Volumn 128, Issue 14, 2015, Pages 1964-1968

  Zhang, En Yuan ^a   Cui, Li ^a   Li, Zhen Yu ^a   Liu, Tong ^a   Li, Guang Ping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Killips; New onset atrial fibrillation

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; ELECTROCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; META ANALYSIS; NEW-ONSET ATRIAL FIBRILLATION; NONHUMAN; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ATRIAL FIBRILLATION; COMPLICATION; HEART INFARCTION; HUMAN; RISK FACTOR;

ATRIAL FIBRILLATION; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 84936988639     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.4103/0366-6999.160565     Document Type: Article

References (29)

1. Jabre P, Roger VL, Murad MH, Chamberlain AM, Prokop L, Adnet F, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: A systematic review and meta-analysis. Circulation 2011; 123: 1587-93.
2. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-45.
3. Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997; 30: 1039-45.
4. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
5. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994; 271: 1615-9.
6. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, et al. Current methods of the US preventive services task force: A review of the process. Am J Prev Med 2001; 20: 21-35.
7. Task Force on the Management of ST-segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-619.
8. Consuegra-Sánchez L, Melgarejo-Moreno A, Galcerá-Tomás J, Alonso-Fernández N, Díaz-Pastor Á, Escudero-García G, et al. Short-and long-term prognosis of previous and new-onset atrial fibrillation in ST-segment elevation acute myocardial infarction. Rev Esp Cardiol (Engl Ed) 2015; 68: 31-8.
9. Lau DH, Huynh LT, Chew DP, Astley CM, Soman A, Sanders P. Prognostic impact of types of atrial fibrillation in acute coronary syndromes. Am J Cardiol 2009; 104: 1317-23.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
11. Gal P, Parlak E, Schellings DA, Beukema R, Ten Berg J, Adiyaman A, et al. Association of serial high sensitivity troponin T with onset of atrial fibrillation in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. Eur Heart J Acute Cardiovasc Care 2015; [Epub ahead of print].
12. Yoshizaki T, Umetani K, Ino Y, Takahashi S, Nakamura M, Seto T, et al. Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction. Intern Med 2012; 51: 1467-71.
13. Bahouth F, Mutlak D, Furman M, Musallam A, Hammerman H, Lessick J, et al. Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction. Heart 2010; 96: 683-8.
14. APEX AMI Investigators, Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes D Jr, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial. JAMA 2007; 297: 43-51.
15. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-45.
16. Galvão Braga C, Ramos V, Vieira C, Martins J, Ribeiro S, Gaspar A, et al. New-onset atrial fibrillation during acute coronary syndromes: Predictors and prognosis. Rev Port Cardiol 2014; 33: 281-7.
17. Dziewierz A, Siudak Z, Rakowski T, Jakala J, Dubiel JS, Dudek D. Prognostic significance of new onset atrial fibrillation in acute coronary syndrome patients treated conservatively. Cardiol J 2010; 17: 57-64.
18. Ruwald AC, Bloch Thomsen PE, Gang U, Jørgensen RM, Huikuri HV, Jons C. New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients-A Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy. Am Heart J 2013; 166: 855-63. e3.
19. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: A systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009; 30: 1038-45.
20. Parashar S, Kella D, Reid KJ, Spertus JA, Tang F, Langberg J, et al. New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry). Am J Cardiol 2013; 112: 1390-5.
21. Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, et al. Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 2006; 8: 591-8.
22. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail 2005; 7: 671-6.
23. Aronson D, Mutlak D, Bahouth F, Bishara R, Hammerman H, Lessick J, et al. Restrictive left ventricular filling pattern and risk of new-onset atrial fibrillation after acute myocardial infarction. Am J Cardiol 2011; 107: 1738-43.
24. Alasady M, Abhayaratna WP, Leong DP, Lim HS, Abed HS, Brooks AG, et al. Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction. Heart Rhythm 2011; 8: 955-60.
25. Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature 2001; 409: 35-6.
26. Guenancia C, Stamboul K, Garnier F, Beer JC, Touzery C, Lorgis L, et al. Obesity and new-onset atrial fibrillation in acute myocardial infarction: A gender specific risk factor. Int J Cardiol 2014; 176: 1039-41.
27. Dorje T, Wang X, Shao M, Zhou J, Cui X, Zhang F, et al. Plasma N-terminal pro-brain natriuretic peptide levels predict new-onset atrial fibrillation in patients with acute myocardial infarction. Int J Cardiol 2013; 168: 3135-7.
28. Olgin JE, Sih HJ, Hanish S, Jayachandran JV, Wu J, Zheng QH, et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation 1998; 98: 2608-14.
29. Jons C, Raatikainen P, Gang UJ, Huikuri HV, Joergensen RM, Johannesen A, et al. Autonomic dsyfunction and new-onset atrial fibrillation in patients with left ventricular systolic dysfunction after acute myocardial infarction: A CARISMA substudy. Heart Rhythm 2011; 8: 342-8.